Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Voyager Therapeutics, Inc.    VYGR

VOYAGER THERAPEUTICS, INC.

(VYGR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/22/2021 01/25/2021 01/26/2021 01/27/2021 01/28/2021 Date
9.04(c) 8.69(c) 8.41(c) 7.73(c) 7.89 Last
318 838 457 014 267 270 430 211 84 682 Volume
+4.51% -3.87% -3.22% -8.09% +2.07% Change
More quotes
Financials (USD)
Sales 2020 181 M - -
Net income 2020 28,9 M - -
Net cash position 2020 198 M - -
P/E ratio 2020 10,1x
Yield 2020 -
Sales 2021 56,0 M - -
Net income 2021 -109 M - -
Net cash position 2021 171 M - -
P/E ratio 2021 -3,01x
Yield 2021 -
Capitalization 290 M 290 M -
EV / Sales 2020 0,51x
EV / Sales 2021 2,11x
Nbr of Employees 186
Free-Float 84,6%
More Financials
Company
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophic lateral sclerosis (ALS); Huntington's disease; Friedreich's ataxia; frontotemporal... 
More about the company
Notations Surperformance© of Voyager Therapeutics, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about VOYAGER THERAPEUTICS, INC.
01/27SHAREHOLDER ACTION NOTICE : The Schall Law Firm Announces the Filing of a Class ..
PR
01/26VYGR SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Notifies Voyager The..
PR
01/26SHAREHOLDER ACTION REMINDER : The Schall Law Firm Announces the Filing of a Clas..
BU
01/25SHAREHOLDER ALERT : Robbins LLP Announces That Voyager Therapeutics, Inc. (VYGR)..
BU
01/25SHAREHOLDER ACTION ALERT : The Schall Law Firm Announces the Filing of a Class A..
BU
01/25VYGR EQUITY ALERT : Rosen Law Firm Announces Filing of Federal Securities Class ..
BU
01/23VOYAGER THERAPEUTICS : Pomerantz Law Firm Announces the Filing of a Class Action..
PR
01/22PRESS RELEASE : BB BIOTECH AG: Vaccines leading -2-
DJ
01/15VOYAGER THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K..
AQ
01/12VOYAGER THERAPEUTICS : Announces Inducement Grants Under Nasdaq Listing Rule 563..
AQ
01/11Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 56..
GL
2020VOYAGER THERAPEUTICS : Cantor Fitzgerald Downgrades Voyager Therapeutics to Neut..
MT
2020AFTER HOURS WATCH LIST SCORECARD : Ocn, sppi, vygr
MT
2020VOYAGER THERAPEUTICS : Raymond James Downgrades Voyager Therapeutics to Market P..
MT
2020MT NEWSWIRES AFTER HOURS WATCH LIST : Ocn, sppi, vygr
MT
More news
News in other languages on VOYAGER THERAPEUTICS, INC.
2019BB Biotech mit höherem Verlust im zweiten Quartal
More news
Analyst Recommendations on VOYAGER THERAPEUTICS, INC.
More recommendations
Chart VOYAGER THERAPEUTICS, INC.
Duration : Period :
Voyager Therapeutics, Inc. Technical Analysis Chart | VYGR | US92915B1061 | MarketScreener
Technical analysis trends VOYAGER THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 14,55 $
Last Close Price 7,73 $
Spread / Highest target 159%
Spread / Average Target 88,2%
Spread / Lowest Target 29,4%
EPS Revisions
Managers and Directors
NameTitle
G. Andre Turenne President, Chief Executive Officer & Director
Michael John Higgins Chairman
Allison Dorval Chief Financial & Accounting Officer
Omar Khwaja Chief Medical Officer, Head-Research & development
Mark Jay Levin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
VOYAGER THERAPEUTICS, INC.8.11%290
MODERNA, INC.49.07%61 624
LONZA GROUP AG3.66%49 275
CELLTRION, INC.-10.58%40 532
IQVIA HOLDINGS INC.-3.44%33 169
SEAGEN INC.-7.11%29 430